Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

116.06
+1.551.35%
Volume:27.33K
Turnover:3.17M
Market Cap:1.04B
PE:94.04
High:116.46
Open:114.98
Low:114.98
Close:114.51
52wk High:118.00
52wk Low:85.91
Shares:8.99M
Float Shares:8.99M
Volume Ratio:1.74
T/O Rate:0.30%
Dividend:2.17
Dividend Rate:1.87%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):149.47

Loading ...

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
1 hour ago

Allergan Aesthetics Unveils Layered Beauty Report on Global Shift Toward Personalized Aesthetic Care

Reuters
·
1 hour ago

Novartis, Alteogen Sign Drug-Technology Deal Worth Up to $3.2 Billion

MT Newswires Live
·
2 hours ago

Alteogen enters option, license agreement with Novartis

TIPRANKS
·
2 hours ago

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
3 hours ago

Novartis Trial Suspensions to Have Limited Financial Impact

Dow Jones
·
5 hours ago

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.
·
13 hours ago

AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
17 hours ago

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
18 hours ago

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
18 hours ago

H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi

TIPRANKS
·
Yesterday

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Yesterday

Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity

Dow Jones
·
Yesterday

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

TIPRANKS
·
Yesterday

Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement

TradingKey
·
Yesterday

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Yesterday

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Yesterday

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Dow Jones
·
Yesterday

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Yesterday

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

TradingKey
·
Yesterday